Mode
Text Size
Log in / Sign up
N/A Completed N=18 Treatment

Adaptation of a Digital Weight Loss Intervention Promoting Self-regulation for Use in Type 2 Diabetes

Type 2 Diabetes Mellitus · Overweight and Obesity
Source: ClinicalTrials.gov NCT03650088 ↗
Enrolled (actual)
18
Serious AEs
0.0%
Results posted
Jan 2023
Primary outcomePrimary: Change in Weight — -4.54 kg

Summary

The purpose of this study is to 1) adapt a weight loss app that the Tate team has previously developed to promote PA and diet and adapt them to the needs and perspectives of those with Type 2 Diabetes (T2DM), integrate daily monitoring of BG using continuous monitoring (CGM) and self-monitoring of diet using the simplified system, and develop appropriate displays of data to facilitate comprehension and decision making, 2) develop the modified intervention and, 3) conduct a pilot and feasibility study on short-term impacts of the intervention in overweight adult patients with T2DM not treated with medications in preparation for an R01 submission.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Weight
-4.54
SECONDARY
Change in Body Mass Index (BMI)
-1.66
SECONDARY
Change in HbA1c Percent
-0.3
SECONDARY
Change in Compliance Behavior and Efforts at Diabetes Self-control
-0.12; -1.35; 0.65
SECONDARY
Change in Diabetes-related Quality of Life: The Diabetes Obstacles Questionnaire (DOQ-30)
-2.88; -2.54; -4.06; -1.24; -3.06; -2.29

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with Type 2 diabetes managed with lifestyle or pre-diabetes
  • HBA1c >= 5.7%
  • BMI 25 - 40 kg/m^2
  • English speaking and writing
  • not adhering the American College of Sports Medicine recommendation of 150 minutes of MVPA/week
  • have a smartphone with internet access

Exclusion Criteria

  • current participation in another physical activity or weight control program
  • report a heart condition, chest pain during periods of activity or rest, or loss of consciousness on the Physical Activity Readiness Questionnaire (PAR-Q; items 1-4)
  • substance abuse or mental health problems that would make it difficult to adhere to the dietary prescription
  • moving out of the area during the study period
  • unable to attend weekly sessions
  • diagnosis of an eating disorder such as bulimia or anorexia
  • currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 6 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03650088). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search